Reversal of electrophysiologic effects of flecainide on the accessory pathway by isoproterenol in the Wolff-Parkinson-White syndrome
- 1 July 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 64 (3) , 194-198
- https://doi.org/10.1016/0002-9149(89)90456-6
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Electrophysiologic effects, efficacy and tolerance of class Ic antiarrhythmic agents in Wolff-Parkinson-White syndromeThe American Journal of Cardiology, 1989
- Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardiaThe American Journal of Cardiology, 1988
- Antagonism of quinidine's electrophysiologic effects by epinephrine in patients with ventricular tachycardiaJournal of the American College of Cardiology, 1988
- Electrophysiologic effects of epinephrine in humansJournal of the American College of Cardiology, 1988
- Sensitivity and specificity of programmed atrial stimulation for induction of supraventricular tachycardiasClinical Cardiology, 1988
- Efficacy of propafenone in Wolff-Parkinson-White syndrome: Electrophysiologic findings and long-term follow-upJournal of the American College of Cardiology, 1987
- Evaluation of flecainide acetate in rapid atrial fibrillation complicating wolff‐parkinson‐white syndromeClinical Cardiology, 1985
- Long Term Use of Flecainide in Patients with Supraventricular TachycardiaDrugs, 1985
- Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.Circulation, 1984
- Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardiasThe American Journal of Cardiology, 1983